Recurrent Melanoma Recruiting Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs